Autologous CD19/CD20 bispecific CAR-T cell therapy generated from T N/MEM cells for
patients with NHL is safe (no neurotoxicity, maximum grade 1 cytokine release syndrome) and …

SspH/IpaH bacterial effector E3 ubiquitin (Ub) ligases, unrelated in sequence or structure to
eukaryotic E3s, are utilized by a wide variety of Gram-negative bacteria during pathogenesis…

CART19/20 was developed by engineering autologous naïve/memory T (T N/MEM ) cells
with a bispecific anti-CD19/CD20 chimeric antigen receptor (CAR) with the goal of mitigating …

50% of patients with relapsed/refractory (R/R) B-cell lymphomas (BCL) who initially respond
to CD19 CAR T therapy will relapse either due to poor CAR-T persistence or CD19 antigen …

Despite excellent responses to anti-CD19 chimeric antigen receptor (CAR)-T cell therapy in
patients with relapsed/refractory (R/R) B-cell non-Hodgkin lymphoma (NHL), more than half …

… Schweppe, our friend, colleague and senior author died suddenly. Fred created spot pricing
… of the key early contributors with his, Tom Sterling's and Ron William's local communication …

The Irish Association of Law Teachers (IALT) was founded in 1979, thanks largely to the
efforts of Professor Robert Heuston, Regius Professor of Law at Trinity College Dublin, who …

Context: Cell lines derived from human cancers provide critical tools to study disease
mechanisms and develop novel therapies. Recent reports indicate that up to 36% of cell lines are …

Mitochondrial protein interactions and complexes facilitate mitochondrial function. These
complexes range from simple dimers to the respirasome supercomplex consisting of oxidative …